Link Between Advandia and Heart Attacks

Jamie Sheller
Attorney
(866) 735-1102 Ext 475
Posted by Jamie ShellerMay 24, 2007 10:39 AM

The FDA has issued a safety alert about the drug Advandia, which is used to treat type-2 diabetes. Data from some trials of the drug show that patients taking Advandia have a potentially serious increased risk of heart attack and heart-related death. Other studies show contradictory results. As of right now, the FDA is not requiring GlaxoSmithKline, the maker of Advandia, to take any action regarding the drug. Rather, doctors and patients should consider this information when making treatment decisions, particularly with diabetes patients who have underlying heart disease or a high heart attack risk. The FDA plans to analyze multiple data sources regarding Advandia and release its results as soon as possible.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Philadelphia

InjuryBoard Philadelphia RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Injury Board Philadelphia is brought to you by Sheller, P.C.

Legal Assistance Center

More Info
Sheller, P.C. (866) 735-1102 Ext 475 www.sheller.com
google
Personal Injury Lawyers Serving: Statewide Pennsylvania, Philadelphia, Norristown, Cheltenham, Chester, Drexel Hill, Folsom, Havertown, King of Prussia, Levittown, Radnor, Springfield, Swarthmore, West Chester, Willow Grove
1528 Walnut Street3rd Floor, Philadelphia, Pennsylvania 19102 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address